AMN Healthcare Services Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
02-22

AMN Healthcare Services (NYSE:AMN) Full Year 2024 Results

Key Financial Results

  • Revenue: US$2.98b (down 21% from FY 2023).
  • Net loss: US$147.0m (down by 170% from US$210.7m profit in FY 2023).
  • US$3.85 loss per share (down from US$5.38 profit in FY 2023).
NYSE:AMN Revenue and Expenses Breakdown February 22nd 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

AMN Healthcare Services Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 1.4%. Earnings per share (EPS) missed analyst estimates.

The primary driver behind last 12 months revenue was the Nurse and Allied Solutions segment contributing a total revenue of US$1.82b (61% of total revenue). Notably, cost of sales worth US$2.06b amounted to 69% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to US$632.5m (59% of total expenses). Explore how AMN's revenue and expenses shape its earnings.

Looking ahead, revenue is expected to decline by 4.3% p.a. on average during the next 2 years, while revenues in the Healthcare industry in the US are expected to grow by 7.2%.

Performance of the American Healthcare industry.

The company's shares are up 18% from a week ago.

Risk Analysis

You should always think about risks. Case in point, we've spotted 1 warning sign for AMN Healthcare Services you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     

如果下載按鈕點擊無跳轉,請點擊右上角菜單選擇 “在瀏覽器打開”